Ovid Therapeutics Inc.OVIDNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-56.03M
↓ 129% below average
Average (9y)
$-24.44M
Historical baseline
Range
High:$118.43M
Low:$-56.65M
CAGR
+29.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-56.03M | -22.0% |
| 2023 | $-45.92M | +18.9% |
| 2022 | $-56.65M | -147.8% |
| 2021 | $118.43M | +327.9% |
| 2020 | $-51.97M | -1.2% |
| 2019 | $-51.33M | -11.8% |
| 2018 | $-45.91M | -45.7% |
| 2017 | $-31.52M | -75.2% |
| 2016 | $-17.99M | -224.6% |
| 2015 | $-5.54M | - |